Clinical Trial: Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Observational




Official Title: Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency

Brief Summary: In the context of the increasing evidence of the pathogenetic role of microbiome in COPD, our aim is to determine the total and specific bacterial and viral load in sputa from patients with COPD due to AATD and to correlate these findings with cellular, biochemical and immunological characteristics of sputa. These quantitative data obtained from sputum will be analyzed in the context of the clinical and physiological parameters of the patients.